Cornwall & Isles of Scilly Community Prescribing and Dispensing News: 2017

Month

Topics

• MHRA Drug Safety Update (November 2017)
• CAPC Technical Working Group
  - Trimbow (beclometasone dipropionate, formoterol fumarate dihydrate, glycopyrronium bromide)
• NICE Guidance
  - CG 185 (Nov 17) - Bipolar disorder
  - CG 71 (Nov 17) - Familial hypercholesterolaemia
  - NG81 (Nov 17) - Glaucoma: diagnosis and management
• NICE Bites - Sinusitis
• Rivaroxaban
  

No 283
October 2017

• MHRA Drug Safety Update (September 2017)
• NICE Guidance
  - PHE 38 (Sept 17) - Type 2 diabetes: prevention in people at high risk public health
  - NG73 (Sept 17) – Endometriosis: diagnosis and management
  - NG78 (Oct 17) - Cystic fibrosis: diagnosis and management
• Osteoporosis
  NICE Bites No 100 September/October 2017 includes two related topics:
  - Osteoporosis; assessing the risk of fragility fracture
  - Bisphosphonates for treating osteoporosis

• Bisphosphonates in osteoporosis

• Prescribing dilemma
• Valproate alert
• Pharmaceutical promotion
• Adverse drug reaction reporting

No 282
August 2017

• MHRA Drug Safety Update (June, July and August 2017)
• NICE Guidance
  - NICE NG 71 (July '17): Parkinson's Disease in adults
  - NICE TA 160 (Aug 17): Alendronate, etidronate, risedronate, raloxifene and strontium ranelate for the primary prevention of osteoporotic fragility fractures in postmenopausal women
  - NICE TA 161 (Aug 17): Alendronate, etidronate, risedronate, raloxifene, strontium ranelate and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women
  - NICE TA 464 (Aug 17): Bisphosphonates (alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid) for treating osteoporosis
• Shared decision making
• Report Illicit Drugs Reactions (RIDR)
• BNF/BNF For Children App

• MHRA Drug Safety Update (May 2017)
• NICE Guidance
  - NICE NG 28 (Updated May '17): Type 2 diabetes in adults
• Quality tip of the month - Anticoagulation in DVT
• Quinine
• Strontium
• Decision aids
• Rightcare patient decision aids
• Enhancing the use of scientific evidence to judge the potential benefits and harms of medicines

• MHRA Drug Safety Update (April 2017)
• CAPC Technical Working Group
  - Insulin aspart fast acting (Fiasp)
  - Diamorphine nasal spray (Ayendi)
  - ADEK Plus multivitamin tablet
• NICE Guidance
  - NICE CG 61 (Updated April '17): Irritable bowel syndrome in adults
  - NICE CG 100 (Updated April '17): Alcohol-use disorders
• Did you see - Fact boxes
• Did you see - Framing your conversation
• Shared Care Guidelines
• Mefenamic acid

• MHRA Drug Safety Update (March 2017)
• CAPC Technical Working Group
  - Opicapone (Ongentys)
  - Ulipristal (Esmya)
  - Calcipotriol / betamethasone foam (Enstilar foam)
  - Tiotropium inhaler (Braltus)
• Eye drop dispensers
• Valproate
• Chronic pain - BMA briefing
• Right Breathe website
• Clinical reasoning and cognition

• MHRA Drug Safety Update (January and February 2017)
• NICE Guidance
  - NICE NG 62 (Jan '17): Cerebral palsy in under 25s
  - NICE NG 63 (Jan '17): Antimicrobial stewardship
  - NICE TA 420 (Dec '16): Ticagrelor for preventing atherothrombotic events after myocardial infarction
• Expectations of benefits and harms
• Standards for reviewing inhaler technique
• Clinical reasoning and cognition
• Asthma guidelines
• Opioid prescribing